280 related articles for article (PubMed ID: 18816045)
21. Inhibition of DNA topoisomerases I and II by G3 PAMAM-NH2 dendrimer-modified digoxin and proscillaridin A conjugates in a cell free system.
Winnicka K; Bielawska A; Bielawski K
Acta Pol Pharm; 2010; 67(6):630-4. PubMed ID: 21229879
[TBL] [Abstract][Full Text] [Related]
22. Topoisomerase IIalpha inhibition following DNA transfection greatly enhances random integration in a human pre-B lymphocyte cell line.
Toyoda E; Kurosawa A; Kamekawa H; Adachi N
Biochem Biophys Res Commun; 2009 May; 382(3):492-6. PubMed ID: 19285952
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studies.
Mandal A; Ghosh S; Bothra AK; Nanda AK; Ghosh P
Eur J Med Chem; 2012 Aug; 54():137-43. PubMed ID: 22633831
[TBL] [Abstract][Full Text] [Related]
24. New PPARgamma ligands based on 2-hydroxy-1,4-naphthoquinone: computer-aided design, synthesis, and receptor-binding studies.
Sundriyal S; Viswanad B; Bharathy E; Ramarao P; Chakraborti AK; Bharatam PV
Bioorg Med Chem Lett; 2008 Jun; 18(11):3192-5. PubMed ID: 18482837
[TBL] [Abstract][Full Text] [Related]
25. A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.
Kondapi AK; Padmaja G; Satyanarayana N; Mukhopadyaya R; Reitz MS
Arch Biochem Biophys; 2005 Sep; 441(1):41-55. PubMed ID: 16091284
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, cytotoxicity, and DNA-topoisomerase inhibitory activity of new asymmetric ureas and thioureas.
Esteves-Souza A; Pissinate K; Nascimento Mda G; Grynberg NF; Echevarria A
Bioorg Med Chem; 2006 Jan; 14(2):492-9. PubMed ID: 16183295
[TBL] [Abstract][Full Text] [Related]
27. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
Lo YC; Ko TP; Su WC; Su TL; Wang AH
J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of DNA topoisomerase II by azaelliptitoxins functionalized in the variable substituent domain.
Tepe JJ; Madalengoitia JS; Slunt KM; Werbovetz KW; Spoors PG; Macdonald TL
J Med Chem; 1996 May; 39(11):2188-96. PubMed ID: 8667362
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I.
Furet P; Schoepfer J; Radimerski T; Chène P
Bioorg Med Chem Lett; 2009 Aug; 19(15):4014-7. PubMed ID: 19560355
[TBL] [Abstract][Full Text] [Related]
30. Thiol-modulated mechanisms of the cytotoxicity of thimerosal and inhibition of DNA topoisomerase II alpha.
Wu X; Liang H; O'Hara KA; Yalowich JC; Hasinoff BB
Chem Res Toxicol; 2008 Feb; 21(2):483-93. PubMed ID: 18197631
[TBL] [Abstract][Full Text] [Related]
31. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for specificity in the poxvirus topoisomerase.
Perry K; Hwang Y; Bushman FD; Van Duyne GD
Mol Cell; 2006 Aug; 23(3):343-54. PubMed ID: 16885024
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.
Pérez-Sacau E; Díaz-Peñate RG; Estévez-Braun A; Ravelo AG; García-Castellano JM; Pardo L; Campillo M
J Med Chem; 2007 Feb; 50(4):696-706. PubMed ID: 17249647
[TBL] [Abstract][Full Text] [Related]
34. Pyranonaphthoquinones--isolation, biological activity and synthesis.
Sperry J; Bachu P; Brimble MA
Nat Prod Rep; 2008 Apr; 25(2):376-400. PubMed ID: 18389142
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and evaluation of octahydropyranopyrrole-based inhibitors of mammalian ribonucleotide reductase.
Fuertes MJ; Kaur J; Deb P; Cooperman BS; Smith AB
Bioorg Med Chem Lett; 2005 Dec; 15(23):5146-9. PubMed ID: 16176875
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel naphthoquinone fused cyclic aminoalkylphosphonates and aminoalkylphosphonic monoester.
Wang B; Miao ZW; Wang J; Chen RY; Zhang XD
Amino Acids; 2008 Aug; 35(2):463-8. PubMed ID: 17665273
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of benz[d]indeno[1,2-b]pyran-5,11-diones: versatile intermediates for the design and synthesis of topoisomerase I inhibitors.
Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M
Bioorg Med Chem Lett; 2006 Apr; 16(7):1846-9. PubMed ID: 16442283
[TBL] [Abstract][Full Text] [Related]
39. Anticancer activity of botanical alkyl hydroquinones attributed to topoisomerase II poisoning.
Huang CP; Fang WH; Lin LI; Chiou RY; Kan LS; Chi NH; Chen YR; Lin TY; Lin SB
Toxicol Appl Pharmacol; 2008 Mar; 227(3):331-8. PubMed ID: 18164362
[TBL] [Abstract][Full Text] [Related]
40. The binding modes and binding affinities of epipodophyllotoxin derivatives with human topoisomerase IIα.
Naik PK; Dubey A; Soni K; Kumar R; Singh H
J Mol Graph Model; 2010 Dec; 29(4):546-64. PubMed ID: 21075653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
